GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » 3-Year RORE %

Vicplas International (SGX:569) 3-Year RORE % : -85.00% (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Vicplas International's 3-Year RORE % for the quarter that ended in Jan. 2024 was -85.00%.

The industry rank for Vicplas International's 3-Year RORE % or its related term are showing as below:

SGX:569's 3-Year RORE % is ranked worse than
89.63% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: -5.21 vs SGX:569: -85.00

Vicplas International 3-Year RORE % Historical Data

The historical data trend for Vicplas International's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International 3-Year RORE % Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 300.00 37.50 44.00 21.21 -38.71

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.59 21.21 -9.09 -38.71 -85.00

Competitive Comparison of Vicplas International's 3-Year RORE %

For the Medical Devices subindustry, Vicplas International's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicplas International's 3-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Vicplas International's 3-Year RORE % falls into.



Vicplas International 3-Year RORE % Calculation

Vicplas International's 3-Year RORE % for the quarter that ended in Jan. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.003-0.02 )/( 0.035-0.015 )
=-0.017/0.02
=-85.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jan. 2024 and 3-year before.


Vicplas International  (SGX:569) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Vicplas International 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Vicplas International's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines